Chief Technology Officer
and access,
Ilan Ben Oren brings more than 20 years’ experience in R&D and management in the medical technology sector. Prior to joining Accelmed, he served as the CTO of Exalenz Bioscience, (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders. Prior to that, he held various positions from project manager to CTO at Oridion Medical (SWX:ORIDN). Mr. Ben-Oren is author of more than 35 patents and patent applications. He holds a Master's degree with special honors, Summa Cum Laude, in Applied Physics and the Science of Materials from the Hebrew University, Jerusalem.
